Balchem Balance Sheet Health
Financial Health criteria checks 6/6
Balchem has a total shareholder equity of $1.2B and total debt of $227.0M, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are $1.6B and $419.7M respectively. Balchem's EBIT is $164.2M making its interest coverage ratio 8.6. It has cash and short-term investments of $73.7M.
Key information
19.3%
Debt to equity ratio
US$227.00m
Debt
| Interest coverage ratio | 8.6x |
| Cash | US$73.69m |
| Equity | US$1.18b |
| Total liabilities | US$419.72m |
| Total assets | US$1.60b |
Recent financial health updates
Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Recent updates
Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Dec 06Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Financial Position Analysis
Short Term Liabilities: BCPC's short term assets ($326.0M) exceed its short term liabilities ($109.4M).
Long Term Liabilities: BCPC's short term assets ($326.0M) exceed its long term liabilities ($310.3M).
Debt to Equity History and Analysis
Debt Level: BCPC's net debt to equity ratio (13%) is considered satisfactory.
Reducing Debt: BCPC's debt to equity ratio has reduced from 30.1% to 19.3% over the past 5 years.
Debt Coverage: BCPC's debt is well covered by operating cash flow (86.8%).
Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (8.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:05 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Balchem Corporation is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |